• LAST PRICE
    2.5200
  • TODAY'S CHANGE (%)
    Trending Up0.2500 (11.0132%)
  • Bid / Lots
    2.4700/ 8
  • Ask / Lots
    2.5500/ 1
  • Open / Previous Close
    2.2800 / 2.2700
  • Day Range
    Low 2.1700
    High 2.6000
  • 52 Week Range
    Low 1.4900
    High 20.6600
  • Volume
    48,454
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.27
TimeVolumeHEPA
09:32 ET2822.26
09:33 ET8502.2699
09:42 ET2002.25
09:46 ET3002.27
10:00 ET1002.255
10:02 ET1002.26
10:04 ET1002.28
10:09 ET1002.255
10:11 ET1372.2737
10:13 ET6002.275
10:15 ET20602.2781
10:18 ET9702.31
10:20 ET2652.31
10:33 ET1002.3306
10:36 ET6002.34
10:38 ET1002.35
10:40 ET1002.35
10:47 ET1452.2792
10:49 ET18572.2
10:54 ET16152.28
11:07 ET5002.295
11:21 ET1472.3
11:30 ET1002.2401
11:34 ET10002.25
11:38 ET10002.232
11:41 ET1002.2501
11:43 ET1002.29
11:45 ET4152.3256
11:54 ET62002.3289
11:56 ET1002.282
12:06 ET6992.2618
12:12 ET1002.32
12:19 ET3002.3239
12:51 ET1002.33
12:57 ET1672.3486
01:02 ET5152.39
01:11 ET10002.42
01:13 ET2102.42
01:18 ET4002.42
01:22 ET2002.415
01:33 ET27992.47
01:36 ET16002.5699
01:38 ET8342.565
01:42 ET3002.5999
01:45 ET3592.6
01:47 ET1002.6
01:54 ET4002.545
02:02 ET1002.5122
02:12 ET18362.5
02:14 ET5982.47
02:27 ET2002.47
02:32 ET70662.52
02:34 ET4002.52
02:36 ET2002.52
02:39 ET5932.52
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesHEPA
Hepion Pharmaceuticals Inc
10.8M
-0.2x
---
United StatesTXTM
Protext Mobility Inc
10.5M
0.0x
---
United StatesPHGE
Biomx Inc
10.6M
-0.3x
---
United StatesNEXI
Neximmune Inc
11.1M
-0.2x
---
United StatesDOMH
Dominari Holdings Inc
11.3M
-0.5x
---
United StatesMNPR
Monopar Therapeutics Inc
9.9M
-1.4x
---
As of 2024-02-22

Company Information

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development of drug therapy for treatment of chronic liver diseases. This therapeutic approach targets fibrosis, inflammation, and the treatment hepatocellular carcinoma (HCC) associated with non-alcoholic steatohepatitis (NASH), viral hepatitis and other liver diseases. The Company's cyclophilin inhibitor, rencofilstat is developed to offer benefits to address multiple complex pathologies relate to advanced liver disease. The Company’s rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. The Company provides an artificial intelligence (AI) tool, AI-POWR, that allows the selection of novel drug targets, biomarkers, and appropriate patient populations. The components of AI-POWR include access to publicly available databases, and in-house genomic and multi-omic big.

Contact Information

Headquarters
399 Thornall StEDISON, NJ, United States 08837-2236
Phone
732-902-4000
Fax
732-902-4100

Executives

Independent Chairman of the Board
John Brancaccio
Interim Chief Executive Officer
John Cavan
Independent Director
Timothy Block
Independent Director
Kaouthar Lbiati

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$10.8M
Revenue (TTM)
$0.00
Shares Outstanding
4.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.46
EPS
$-12.51
Book Value
$13.08
P/E Ratio
-0.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.